JP2002534506A5 - - Google Patents

Download PDF

Info

Publication number
JP2002534506A5
JP2002534506A5 JP2000593586A JP2000593586A JP2002534506A5 JP 2002534506 A5 JP2002534506 A5 JP 2002534506A5 JP 2000593586 A JP2000593586 A JP 2000593586A JP 2000593586 A JP2000593586 A JP 2000593586A JP 2002534506 A5 JP2002534506 A5 JP 2002534506A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
hydrogen
substituted
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000593586A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002534506A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/000151 external-priority patent/WO2000042018A1/en
Publication of JP2002534506A publication Critical patent/JP2002534506A/ja
Publication of JP2002534506A5 publication Critical patent/JP2002534506A5/ja
Withdrawn legal-status Critical Current

Links

JP2000593586A 1999-01-15 2000-01-12 Pde−iv抑制作用を有する多重に置換された6−フェニルフェナントリジン Withdrawn JP2002534506A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99100696.6 1999-01-15
EP99100696 1999-01-15
PCT/EP2000/000151 WO2000042018A1 (en) 1999-01-15 2000-01-12 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity

Publications (2)

Publication Number Publication Date
JP2002534506A JP2002534506A (ja) 2002-10-15
JP2002534506A5 true JP2002534506A5 (cg-RX-API-DMAC7.html) 2007-03-01

Family

ID=8237352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000593586A Withdrawn JP2002534506A (ja) 1999-01-15 2000-01-12 Pde−iv抑制作用を有する多重に置換された6−フェニルフェナントリジン

Country Status (8)

Country Link
US (1) US6534518B1 (cg-RX-API-DMAC7.html)
EP (1) EP1163226B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002534506A (cg-RX-API-DMAC7.html)
AT (1) ATE356810T1 (cg-RX-API-DMAC7.html)
AU (1) AU2904300A (cg-RX-API-DMAC7.html)
CA (1) CA2360386A1 (cg-RX-API-DMAC7.html)
DE (1) DE60033918D1 (cg-RX-API-DMAC7.html)
WO (1) WO2000042018A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1303506T1 (en) 2000-07-14 2005-06-30 Altana Pharma Ag 6-heteroarylphenanthridines
AU2001267589A1 (en) * 2000-07-14 2002-01-30 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
AU2000270300A1 (en) * 2000-09-13 2002-03-26 Isis Innovation Limited Use of phosphodiesterase inhibitors for the treatment of anorectal disorders
CA2495597A1 (en) * 2002-08-17 2004-03-04 Altana Pharma Ag Novel phenanthridines
AU2003255493B8 (en) 2002-08-29 2009-03-26 Takeda Gmbh 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
CA2496459C (en) 2002-08-29 2013-06-25 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
US6894061B2 (en) 2002-12-04 2005-05-17 Wyeth Substituted dihydrophenanthridinesulfonamides
JP2007500686A (ja) * 2003-07-31 2007-01-18 アルタナ ファルマ アクチエンゲゼルシャフト 新規の6−フェニルフェナントリジン
EP1658270A1 (en) * 2003-07-31 2006-05-24 ALTANA Pharma AG Novel 6-phenylphenantridines
EP1720835B1 (en) 2004-02-18 2012-12-12 Nycomed GmbH Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors
PL2589599T4 (pl) 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
US7589205B2 (en) * 2004-09-08 2009-09-15 Nycomed Gmbh 3-thia-10-aza-phenanthrene derivatives
DE602005027866D1 (de) * 2004-09-08 2011-06-16 Nycomed Gmbh 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4-inhibitoren
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
ES2337083T3 (es) 2005-03-02 2010-04-20 Nycomed Gmbh (2r,4ar,10br)-6-(2,6-dimetoxipiridin-3-il)-9-exoti-8-metoxi-1,2,3,4,4a,10b-hexahidrofenantridin-2-ol, sal de hc1.
AU2006221957A1 (en) * 2005-03-09 2006-09-14 Nycomed Gmbh Amido-substituted 6-phenylphenanthridines
KR101178674B1 (ko) 2007-10-04 2012-08-30 에프. 호프만-라 로슈 아게 사이클로프로필 아릴 아마이드 유도체 및 이의 용도
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
GB8800397D0 (en) 1988-01-08 1988-02-10 Sandoz Ltd Improvements in/relating to organic compounds
EE03523B1 (et) 1996-01-31 2001-10-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
US6127378A (en) 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
CA2250569C (en) * 1996-03-26 2005-05-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel phenanthridines substituted in the 6 position
DK0937074T3 (da) * 1996-11-11 2003-06-23 Altana Pharma Ag Benzonaphthyridiner som bronkiale terapeutiske midler
GB9626643D0 (en) 1996-12-21 1997-02-12 Astra Pharma Prod Compounds
SI0968211T1 (en) 1997-03-07 2004-02-29 Altana Pharma Ag Tetrazole derivatives
PT1000035E (pt) 1997-07-25 2003-04-30 Altana Pharma Ag 6-fenilfenantridinas substituidas
AU753615B2 (en) 1997-07-25 2002-10-24 Altana Pharma Ag Novel tetrazole derivatives
SI1109810T1 (en) 1998-08-31 2004-12-31 Altana Pharma Ag Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity

Similar Documents

Publication Publication Date Title
JP2002534508A5 (cg-RX-API-DMAC7.html)
RU2009121775A (ru) Пиридильное неароматическое азот-содержащее гетероцикло-1-карбоксилатное производное
JP2006520805A5 (cg-RX-API-DMAC7.html)
JP2018511631A5 (cg-RX-API-DMAC7.html)
JP2006508913A5 (cg-RX-API-DMAC7.html)
JP2009518317A5 (cg-RX-API-DMAC7.html)
JP2008509187A5 (cg-RX-API-DMAC7.html)
AR051790A1 (es) Tratamiento de tuberculosis latente
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
CY1110676T1 (el) ΠΥΡΑΖΟΛΟ[3,4-b]ΠΥΡΙΔΙΝΙΚΕΣ ΕΝΩΣΕΙΣ, ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ ΦΩΣΦΟΔΙΕΣΤΕΡΑΣΗΣ
JP2010535799A5 (cg-RX-API-DMAC7.html)
RU2007101309A (ru) Боросодержащее соединение и способы применения
PT1384477E (pt) Utilizacao de derivados de pirazolina na preparacao de um medicamento para a prevencao e/ou tratamento de doencas proliferativas celulares
NZ503294A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives and pharmaceutical use
JP2008517913A5 (cg-RX-API-DMAC7.html)
JP2007530582A5 (cg-RX-API-DMAC7.html)
MY121852A (en) 4-(aminoethyl)-piperidine benzamides for treating gastrointestinal disorders
JP2003502278A5 (cg-RX-API-DMAC7.html)
JP2005538111A5 (cg-RX-API-DMAC7.html)
ZA200600693B (en) Combination of mGluR2 antagonist and AChE inhibitor for treatment of acute and/or chronic neurological disorders
JP2019529487A5 (cg-RX-API-DMAC7.html)
JP2003512327A5 (cg-RX-API-DMAC7.html)
JP2005527521A5 (cg-RX-API-DMAC7.html)
JP2003513075A5 (cg-RX-API-DMAC7.html)
CY1105208T1 (el) Ετepοαρυλ παραγωγα σαν ανωτepοι συνδετηρες για τον υποδοχεα nociceptin orl-1